Drug · DIN 02542536 · Veterinary
BUPRIXA
MULTIDOSE VIAL
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since January 30, 2024.
- Drug Identification Number (DIN)
- 02542536
- Company (DIN owner)
- Zoetis Canada IncKirkland, Quebec, Canada
- Schedule
- Narcotics (cdsa i)
- Dosage form
- Solution
- Route
- Intramuscular
- Class
- Veterinary
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) | 0.3 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 30, 2024: NOC 32772Abbreviated New Drug Submission (ANDS) · Administrative - Manufacturer and Product Name Change
- October 27, 2023: NOC 31946Abbreviated New Drug Submission (ANDS)